Showing results (211-220 of 233) with videos related to
Sort By:
Pageof 24
Blood|August 15, 1996
Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancerB Eibl, H Schwaighofer, D Nachbaur, et al.International Journal of Cancer|September 17, 1996
Different effects of interferons, interleukin-1beta and tumor necrosis factor-alpha in normal (OSE) and malignant human ovarian epithelial cellsC Marth, A G Zeimet, M Herold, et al.Gynakologisch-Geburtshilfliche Rundschau|January 1, 1992
[Interferon-gamma suppresses expression of the HER-2 oncogene in ovarian cancer cells]C Marth, E Müller-Holzner, A G Zeimet, et al.Cytokine|July 6, 2000
Regulation of transforming growth factor-beta secretion by human peritoneal mesothelial and ovarian carcinoma cellsB Abendstein, S Stadlmann, C Knabbe, et al.British Journal of Cancer|February 9, 2012
Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trialV Seebacher, S Polterauer, C Grimm, et al.British Journal of Cancer|January 15, 1999
Retinoic acid modulates prolactin receptor expression and prolactin-induced STAT-5 activation in breast cancer cells in vitroM Widschwendter, A Widschwendter, T Welte, et al.Journal of the National Cancer Institute|May 18, 2000
Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancerM Widschwendter, J Berger, M Hermann, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2015
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-upN Colombo, C Creutzberg, F Amant, et al.British Journal of Cancer|July 28, 2012
Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patientsU Wagner, C Marth, R Largillier, et al.Oncogene|April 26, 2011
Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancerD Reimer, M Hubalek, H Kiefel, et al.Pageof 24